By Scientia Professor Matthew Colm Kiernan

Journal articles

Devenney EM; Tu S; Caga J; Ahmed RM; Ramsey E; Zoing M; Kwok J; Halliday GM; Piguet O; Hodges JR; Kiernan MC, 2021, 'Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS-FTD spectrum', Annals of Clinical and Translational Neurology, 8, pp. 1576 - 1591, http://dx.doi.org/10.1002/acn3.51363

Kiernan MC, 2021, 'Neurology and clinical neurophysiology: An artificial divide', Practical Neurology, 21, pp. 274 - 275, http://dx.doi.org/10.1136/practneurol-2021-002946

Tu S; Huang M; Caga J; Mahoney CJ; Kiernan MC, 2021, 'Brainstem Correlates of Pathological Laughter and Crying Frequency in ALS', Frontiers in Neurology, 12, http://dx.doi.org/10.3389/fneur.2021.704059

Forrest SL; Kim JH; De Sousa C; Cheong R; Crockford DR; Sheedy D; Stevens J; McCrossin T; Tan RH; McCann H; Shepherd CE; Rowe DB; Kiernan MC; Halliday GM; Kril JJ, 2021, 'Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis', European Journal of Neurology, 28, pp. 2192 - 2199, http://dx.doi.org/10.1111/ene.14849

Fifita JA; Chan Moi Fat S; McCann EP; Williams KL; Twine NA; Bauer DC; Rowe DB; Pamphlett R; Kiernan MC; Tan VX; Blair IP; Guillemin GJ, 2021, 'Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis', Frontiers in Immunology, 12, http://dx.doi.org/10.3389/fimmu.2021.701550

Ahmed RM; Kiernan MC, 2021, 'Author Response: Phenotypic Variability in ALS-FTD and Effect on Survival', Neurology, 96, pp. 1103 - 1104, http://dx.doi.org/10.1212/WNL.0000000000012073

Nguyen C; Caga J; Mahoney CJ; Kiernan MC; Huynh W, 2021, 'Behavioural changes predict poorer survival in amyotrophic lateral sclerosis', Brain and Cognition, 150, http://dx.doi.org/10.1016/j.bandc.2021.105710

Ahmed RM; Tse NY; Chen Y; Henning E; Hodges JR; Kiernan MC; Irish M; Farooqi IS; Piguet O, 2021, 'Neural correlates of fat preference in frontotemporal dementia: translating insights from the obesity literature', Annals of Clinical and Translational Neurology, 8, pp. 1318 - 1329, http://dx.doi.org/10.1002/acn3.51369

Hannaford A; Pavey N; van den Bos M; Geevasinga N; Menon P; Shefner JM; Kiernan MC; Vucic S, 2021, 'Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis', Annals of Neurology, 89, pp. 979 - 986, http://dx.doi.org/10.1002/ana.26045

Chan Moi Fat S; McCann EP; Williams KL; Henden L; Twine NA; Bauer DC; Pamphlett R; Kiernan MC; Rowe DB; Nicholson GA; Fifita JA; Blair IP, 2021, 'Genetic analysis of GLT8D1 and ARPP21 in Australian familial and sporadic amyotrophic lateral sclerosis', Neurobiology of Aging, 101, pp. 297.e9 - 297.e11, http://dx.doi.org/10.1016/j.neurobiolaging.2021.01.005

Mahoney CJ; Ahmed RM; Huynh W; Tu S; Rohrer JD; Bedlack RS; Hardiman O; Kiernan MC, 2021, 'Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis', CNS Drugs, 35, pp. 483 - 505, http://dx.doi.org/10.1007/s40263-021-00820-1

Timmins HC; Li T; Trinh T; Kiernan MC; Harrison M; Boyle F; Friedlander M; Goldstein D; Park SB, 2021, 'Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response', Oncologist, 26, pp. 366 - 374, http://dx.doi.org/10.1002/onco.13697

Higashihara M; Pavey N; Van Den Bos M; Menon P; Kiernan MC; Vucic S, 2021, 'Association of Cortical Hyperexcitability and Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis', Neurology, 96, pp. E2090 - E2097, http://dx.doi.org/10.1212/WNL.0000000000011798

Garcia-Montojo M; Fathi S; Norato G; Smith BR; Rowe DB; Kiernan MC; Vucic S; Mathers S; van Eijk RPA; Santamaria U; Rogers ML; Malaspina A; Lombardi V; Mehta PR; Westeneng HJ; van den Berg LH; Al-Chalabi A; Gold J; Nath A, 2021, 'Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy', Journal of the Neurological Sciences, 423, http://dx.doi.org/10.1016/j.jns.2021.117358

Huynh W; Tu S; Mahoney CJ; Schwartz R; Kiernan MC, 2021, 'Mills Syndrome: Clinical and Radiologic Asymmetry', Neurology, 96, pp. 677 - 678, http://dx.doi.org/10.1212/WNL.0000000000011710

van den Bos MAJ; Higashihara M; Geevasinga N; Menon P; Kiernan MC; Vucic S, 2021, 'Pathophysiological associations of transcallosal dysfunction in ALS', European Journal of Neurology, 28, pp. 1172 - 1180, http://dx.doi.org/10.1111/ene.14653

El-Wahsh S; Finger EC; Piguet O; Mok V; Rohrer JD; Kiernan MC; Ahmed RM, 2021, 'Predictors of survival in frontotemporal lobar degeneration syndromes', Journal of Neurology, Neurosurgery and Psychiatry, 92, pp. 425 - 433, http://dx.doi.org/10.1136/jnnp-2020-324349

Weiss MD; Macklin EA; McIlduff CE; Vucic S; Wainger BJ; Kiernan MC; Goutman SA; Goyal NA; Rutkove SB; Ladha SS; Chen IHA; Harms MB; Brannagan TH; Lacomis D; Zivkovic S; Ma M; Wang LH; Simmons Z; Rivner MH; Shefner JM; Cudkowicz ME; Atassi N, 2021, 'Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial', Muscle and Nerve, 63, pp. 371 - 383, http://dx.doi.org/10.1002/mus.27146

Wainger BJ; Macklin EA; Vucic S; McIlduff CE; Paganoni S; Maragakis NJ; Bedlack R; Goyal NA; Rutkove SB; Lange DJ; Rivner MH; Goutman SA; Ladha SS; Mauricio EA; Baloh RH; Simmons Z; Pothier L; Kassis SB; La T; Hall M; Evora A; Klements D; Hurtado A; Pereira JD; Koh J; Celnik PA; Chaudhry V; Gable K; Juel VC; Phielipp N; Marei A; Rosenquist P; Meehan S; Oskarsson B; Lewis RA; Kaur D; Kiskinis E; Woolf CJ; Eggan K; Weiss MD; Berry JD; David WS; Davila-Perez P; Camprodon JA; Pascual-Leone A; Kiernan MC; Shefner JM; Atassi N; Cudkowicz ME, 2021, 'Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial', JAMA Neurology, 78, pp. 186 - 196, http://dx.doi.org/10.1001/jamaneurol.2020.4300

McCann EP; Henden L; Fifita JA; Zhang KY; Grima N; Bauer DC; Chan Moi Fat S; Twine NA; Pamphlett R; Kiernan MC; Rowe DB; Williams KL; Blair IP, 2021, 'Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis', Journal of Medical Genetics, 58, pp. 87 - 95, http://dx.doi.org/10.1136/jmedgenet-2020-106866

Kiernan MC; Vucic S; Talbot K; McDermott CJ; Hardiman O; Shefner JM; Al-Chalabi A; Huynh W; Cudkowicz M; Talman P; Van den Berg LH; Dharmadasa T; Wicks P; Reilly C; Turner MR, 2021, 'Improving clinical trial outcomes in amyotrophic lateral sclerosis', Nature Reviews Neurology, 17, pp. 104 - 118, http://dx.doi.org/10.1038/s41582-020-00434-z

Trinh T; Park SB; Murray J; Pickering H; Lin CSY; Martin A; Friedlander M; Kiernan MC; Goldstein D; Krishnan AV, 2021, 'Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy—a randomised controlled trial', Supportive Care in Cancer, 29, pp. 1103 - 1110, http://dx.doi.org/10.1007/s00520-020-05591-x

Vucic S; Kiernan MC; Menon P; Huynh W; Rynders A; Ho KS; Glanzman R; Hotchkin MT, 2021, 'Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression', BMJ open, 11, pp. e041479, http://dx.doi.org/10.1136/bmjopen-2020-041479

Shefner JM; Andrews JA; Genge A; Jackson C; Lechtzin N; Miller TM; Cockroft BM; Meng L; Wei J; Wolff AA; Malik FI; Bodkin C; Brooks BR; Caress J; Dionne A; Fee D; Goutman SA; Goyal NA; Hardiman O; Hayat G; Heiman-Patterson T; Heitzman D; Henderson RD; Johnston W; Karam C; Kiernan MC; Kolb SJ; Korngut L; Ladha S; Matte G; Mora JS; Needham M; Oskarsson B; Pattee GL; Pioro EP; Pulley M; Quan D; Rezania K; Schellenberg KL; Schultz D; Shoesmith C; Simmons Z; Statland J; Sultan S; Swenson A; Berg LHVD; Vu T; Vucic S; Weiss M; Whyte-Rayson A; Wymer J; Zinman L; Rudnicki SA, 2021, 'A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22, pp. 287 - 299, http://dx.doi.org/10.1080/21678421.2020.1822410

Bedlack R; Armon C; Barkhaus P; Barnes B; Bereman M; Bertorini T; Carter G; Chen A; Crayle J; Cudkowicz M; Jackson C; Kiernan M; Levitsky G; McDermott C; Pattee G; Pioro E; Salmon K; Staats K; Stephens J; Wicks P, 2021, 'ALSUntangled 57: Vinpocetine', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22, pp. 316 - 319, http://dx.doi.org/10.1080/21678421.2020.1786942

Dharmadasa T; Howells J; Matamala JM; Simon NG; Burke D; Vucic S; Kiernan MC, 2021, 'Cortical inexcitability defines an adverse clinical profile in amyotrophic lateral sclerosis', European Journal of Neurology, 28, pp. 90 - 97, http://dx.doi.org/10.1111/ene.14515

Rinaldi S; Davies A; Fehmi J; Beadnall HN; Wang J; Hardy TA; Barnett MH; Broadley SA; Waters P; Reddel SW; Irani SR; Brilot F; Dale RC; Ramanathan S, 2021, 'Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders', Neurology(R) neuroimmunology & neuroinflammation, 8, http://dx.doi.org/10.1212/NXI.0000000000000924

Caga J; Zoing MC; Foxe D; Ramsey E; D’Mello M; Mioshi E; Ahmed RM; Kiernan MC; Piguet O, 2021, 'Problem-focused coping underlying lower caregiver burden in ALS-FTD: implications for caregiver intervention', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22, pp. 434 - 441, http://dx.doi.org/10.1080/21678421.2020.1867180

Hannaford A; Vucic S; Kiernan MC; Simon NG, 2021, 'Review article “spotlight on ultrasonography in the diagnosis of peripheral nerve disease: The evidence to date”', International Journal of General Medicine, 14, pp. 4579 - 4604, http://dx.doi.org/10.2147/IJGM.S295851

Ahmed RM; Bocchetta M; Todd EG; Tse NY; Devenney EM; Tu S; Caga J; Hodges JR; Halliday GM; Irish M; Kiernan MC; Piguet O; Rohrer JD, 2021, 'Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach', Brain Communications, 3, http://dx.doi.org/10.1093/braincomms/fcab257

De Boer EMJ; Orie VK; Williams T; Baker MR; De Oliveira HM; Polvikoski T; Silsby M; Menon P; Van Den Bos M; Halliday GM; Van Den Berg LH; Van Den Bosch L; Van Damme P; Kiernan M; Van Es MA; Vucic S, 2021, 'TDP-43 proteinopathies: A new wave of neurodegenerative diseases', Journal of Neurology, Neurosurgery and Psychiatry, 92, pp. 86 - 95, http://dx.doi.org/10.1136/jnnp-2020-322983

Katzeff JS; Bright F; Lo K; Kril JJ; Connolly A; Crossett B; Ittner LM; Kassiou M; Loy CT; Hodges JR; Piguet O; Kiernan MC; Halliday GM; Kim WS, 2020, 'Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation', Scientific Reports, 10, http://dx.doi.org/10.1038/s41598-020-70687-7

Kiernan MC, 2020, 'Fasciculation anxiety syndrome in clinicians: FASICS', Practical Neurology, 20, pp. 433 - 434, http://dx.doi.org/10.1136/practneurol-2020-002786

Henden L; Twine NA; Szul P; McCann EP; Nicholson GA; Rowe DB; Kiernan MC; Bauer DC; Blair IP; Williams KL, 2020, 'Identity by descent analysis identifies founder events and links SOD1 familial and sporadic ALS cases', npj Genomic Medicine, 5, http://dx.doi.org/10.1038/s41525-020-00139-8

Park SB; Thurbon R; Kiernan MC, 2020, 'Isaacs syndrome: The frontier of neurology, psychiatry, immunology and cancer', Journal of Neurology, Neurosurgery and Psychiatry, 91, pp. 1243 - 1244, http://dx.doi.org/10.1136/jnnp-2020-324675

Kiernan MC, 2020, 'Metabolomic insights into neurodegene­ rative disease', Journal of Neurology, Neurosurgery and Psychiatry, 91, pp. 1250, http://dx.doi.org/10.1136/jnnp-2020-324856

Cooper-Knock J; Zhang S; Kenna KP; Moll T; Franklin JP; Allen S; Nezhad HG; Iacoangeli A; Yacovzada NY; Eitan C; Hornstein E; Ehilak E; Celadova P; Bose D; Farhan S; Fishilevich S; Lancet D; Morrison KE; Shaw CE; Al-Chalabi A; Blair I; Wray N; Kiernan M; Neto MM; Chio A; Cauchi R; Robberecht W; van Damme P; Corcia P; Couratier P; Hardiman O; McLaughlin R; Gotkine M; Drory V; Ticozzi N; Silani V; Veldink J; van den Berg L; de Carvalho M; Pardina JM; Povedano M; Andersen P; Wber M; Başak N; Shaw C; Shaw P; Morrison K; Landers J; Glass J; Veldink JH; Kirby J; Snyder MP; Shaw PJ, 2020, 'Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene', Cell Reports, 33, http://dx.doi.org/10.1016/j.celrep.2020.108456

Farrar MA; Kiernan MC, 2020, 'Spinal muscular atrophy — the dawning of a new era', Nature Reviews Neurology, 16, pp. 593 - 594, http://dx.doi.org/10.1038/s41582-020-00410-7

Farrar MA; Kiernan MC, 2020, 'Treating adults with spinal muscular atrophy with nusinersen', Journal of Neurology, Neurosurgery and Psychiatry, 91, pp. 1139, http://dx.doi.org/10.1136/jnnp-2020-324036

Tammi SM; Tounsi WA; Sainio S; Kiernan M; Avent ND; Madgett TE; Haimila K, 2020, 'Next-generation sequencing of 35 RHD variants in 16 253 serologically D- pregnant women in the Finnish population', BLOOD ADVANCES, 4, pp. 4994 - 5001, http://dx.doi.org/10.1182/bloodadvances.2020001569

Su L; Hironaka CE; Chen FY; Couper GS; Kiernan MS; Kawabori M, 2020, 'Untwist the twist: instant hemodynamic improvement in known HeartMate 3 complication', JOURNAL OF ARTIFICIAL ORGANS, 24, pp. 365 - 367, http://dx.doi.org/10.1007/s10047-020-01220-w

Kiernan MC; Shefner JM; Kaji R; Burke D, 2020, 'Amyotrophic lateral sclerosis: A new diagnostic paradigm', Journal of Neurology, Neurosurgery and Psychiatry, 91, pp. 903 - 904, http://dx.doi.org/10.1136/jnnp-2020-324006

Tracy JA; Taylor BV; Kiernan M; Dyck PJ; Crum BA; Mauermann ML; Amrami KK; Spinner RJ; Dyck PJB, 2020, 'Nerve Pathology Distinguishes Focal Motor Chronic Inflammatory Demyelinating Polyradiculoneuropathy from Multifocal Motor Neuropathy', Journal of Clinical Neuromuscular Disease, 22, pp. 1 - 10, http://dx.doi.org/10.1097/CND.0000000000000279

Timmins HC; Li T; Kiernan MC; Baron-Hay S; Marx G; Boyle F; Goldstein D; Park SB, 2020, 'Taxane-induced peripheral neuropathy: differences in patient report and objective assessment', Supportive Care in Cancer, 28, pp. 4459 - 4466, http://dx.doi.org/10.1007/s00520-020-05299-y

Shefner JM; Al-Chalabi A; Baker MR; Cui LY; de Carvalho M; Eisen A; Grosskreutz J; Hardiman O; Henderson R; Matamala JM; Mitsumoto H; Paulus W; Simon N; Swash M; Talbot K; Turner MR; Ugawa Y; van den Berg LH; Verdugo R; Vucic S; Kaji R; Burke D; Kiernan MC, 2020, 'A proposal for new diagnostic criteria for ALS', Clinical Neurophysiology, 131, pp. 1975 - 1978, http://dx.doi.org/10.1016/j.clinph.2020.04.005

Li T; Timmins HC; King T; Kiernan MC; Goldstein D; Park SB, 2020, 'Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials', Hematological Oncology, 38, pp. 229 - 243, http://dx.doi.org/10.1002/hon.2706

Besomi M; Hodges PW; Clancy EA; Van Dieën J; Hug F; Lowery M; Merletti R; Søgaard K; Wrigley T; Besier T; Carson RG; Disselhorst-Klug C; Enoka RM; Falla D; Farina D; Gandevia S; Holobar A; Kiernan MC; McGill K; Perreault E; Rothwell JC; Tucker K, 2020, 'Consensus for experimental design in electromyography (CEDE) project: Amplitude normalization matrix', Journal of Electromyography and Kinesiology, 53, http://dx.doi.org/10.1016/j.jelekin.2020.102438

Timmins HC; Li T; Huynh W; Kiernan MC; Baron-Hay S; Boyle F; Goldstein D; Park SB, 2020, 'Electrophysiological and phenotypic profiles of taxane-induced neuropathy', Clinical Neurophysiology, 131, pp. 1979 - 1985, http://dx.doi.org/10.1016/j.clinph.2020.02.028

Edwards LS; Halmagyi GM; Mallawaarachchi A; Thompson EO; Kiernan MC, 2020, 'Fatal cerebellar oedema in adult Leigh syndrome', Practical Neurology, 20, pp. 338 - 339, http://dx.doi.org/10.1136/practneurol-2019-002409

Howells J; Sangari S; Matamala JM; Kiernan MC; Marchand-Pauvert V; Burke D, 2020, 'Interrogating interneurone function using threshold tracking of the H reflex in healthy subjects and patients with motor neurone disease', Clinical Neurophysiology, 131, pp. 1986 - 1996, http://dx.doi.org/10.1016/j.clinph.2020.03.028

Back to profile page